ACSL4 and cancer: Finally, the central role of ACSL4 activity in mediating ferroptosis offers an additional, compelling rationale for determining the status of its expression in breast as well as other cancers, since only those cancers positive for its expression are sensitive to induction of classical ferroptosis as a possible treatment modality.